Stiftung Warentest: Vernichtendes Urteil über CBD-Präparate pharmazeutische-zeitung.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmazeutische-zeitung.de Daily Mail and Mail on Sunday newspapers.
The Worldwide Chromatography Instruments Industry is Projected to Reach $11 Billion by 2025
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global chromatography instruments market is projected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020 at a CAGR of 5.1%.
Growth in the chromatography instruments market can be attributed to increasing investments by pharma and biotech companies in R&D activities, growing demand for hyphenated chromatography techniques, and rising adoption of chromatography techniques across various industries. However, the dearth of skilled professionals and high costs of advanced chromatography instruments may restrain market growth.
The COVID-19 pandemic has upended many lives and businesses on an unprecedented scale. The analytical instrumentation sector is facing challenges in its manufacturing and supply chain, such as delivering products to end-users in a timely manner as well as attending
Hacker verbreiten gestohlene Impfstoffdaten im Internet zdnet.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zdnet.de Daily Mail and Mail on Sunday newspapers.
This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
A top healthcare VC predicted microbiome drugs would rebound in 2021 as part of Business Insider s year-end roundup of healthcare predictions.
Though the biotech industry s infatuation with the promise of the bacteria in our gut dates back years, research failures and the 2019 uBiome scandal previously chilled investors interests.
More established microbiome companies have continued the search to prove the microbiome can bear fruit for patients and investors alike.
Seres Therapeutics, currently valued at $2.4 billion, is the space s clear frontrunner, having announced success last August in a late-stage study for one of its microbiome drug candidates.
BioNTech und Aristo Group: Partner bei der Entwicklung des COVID-19-Impfstoffs finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.